Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 6 of 6 drugs
| No. | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | |||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Dalfampridine | 7件: 4-Aminopyridine 4-Aminopyridine; 4-AP; AMPYRA; Dalfampridine; FAMPRIDINA; FAMPRIDINE; FAMPYRA | 1件: Dalfampridine
Dalfampridine
💬1. Dalfampridine
| 4件: KCNA4 KCNA4,KCNC3, KCND2, KCND3 💬 | 4件: Cortisol synthesis and secretion Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia 💬 4件: Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia ... | 5件: 3 3, 4, 6, 13, 14 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | Dexmedetomidine | 4件: Dexdor Dexdor; DEXMEDETOMIDINA; Dexmedetomidine; DEXMEDETOMIDINE HYDROCHLORIDE | 1件: Dexmedetomidine
Dexmedetomidine
💬2. Dexmedetomidine
| 3件: ADRA2A ADRA2A,ADRA2B, ADRA2C 💬 | 2件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 💬 | 14件: 2 2, 4, 6, 21, 34, 46, 70, 107, 113, 171, 212, 215, 226, 280 💬2. Dexmedetomidine
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | Esketamine | 3件: ESKETAMINE ESKETAMINE; KETAMINE; S-ketamine | 1件: Esketamine
Esketamine
💬3. Esketamine
| 5件: GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 3. Esketamine | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | 3件: 2 2, 4, 70 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 4 | Ketamine | 2件: Ketamine Ketamine; NMDA | 1件: Ketamine
Ketamine
💬4. Ketamine
| 5件: GRIN1 GRIN1,GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 4. Ketamine | 20件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium si ... | 8件: 2 2, 4, 6, 13, 70, 113, 156, 215 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | Levetiracetam | 2件: KEPPRA KEPPRA; Levetiracetam | 1件: Levetiracetam
Levetiracetam
💬5. Levetiracetam
| 1件: SV2A SV2A 💬5. Levetiracetam
| 1件: ECM-receptor interaction ECM-receptor interaction 💬 | 5件: 2 2, 4, 6, 13, 307 💬
| |||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | Pyrimethamine | 2件: Daraprim Daraprim; Pyrimethamine | 1件: Pyrimethamine
Pyrimethamine
💬6. Pyrimethamine
| - | - | 12件: 2 2, 4, 6, 13, 19, 46, 51, 63, 65, 96, 97, 265 💬6. Pyrimethamine
|